These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 28779075)

  • 1. Pathogenicity and peramivir efficacy in immunocompromised murine models of influenza B virus infection.
    Pascua PNQ; Mostafa HH; Marathe BM; Vogel P; Russell CJ; Webby RJ; Govorkova EA
    Sci Rep; 2017 Aug; 7(1):7345. PubMed ID: 28779075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.
    Marathe BM; Mostafa HH; Vogel P; Pascua PNQ; Jones JC; Russell CJ; Webby RJ; Govorkova EA
    Antiviral Res; 2017 Dec; 148():20-31. PubMed ID: 29100887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model.
    Pascua PNQ; Marathe BM; Vogel P; Webby RJ; Govorkova EA
    J Antimicrob Chemother; 2019 May; 74(5):1333-1341. PubMed ID: 30715325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae.
    Onishi M; Kitano M; Taniguchi K; Homma T; Kobayashi M; Yoshinaga T; Naito A; Sato A
    Antiviral Res; 2015 May; 117():52-9. PubMed ID: 25752738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.
    Kobayashi M; Kodama M; Noshi T; Yoshida R; Kanazu T; Nomura N; Soda K; Isoda N; Okamatsu M; Sakoda Y; Yamano Y; Sato A; Kida H
    Antiviral Res; 2017 Mar; 139():41-48. PubMed ID: 28012921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Antiviral Properties of Peramivir against H7N9 Avian Influenza Virus in an Experimental Mouse Model.
    Farooqui A; Huang L; Wu S; Cai Y; Su M; Lin P; Chen W; Fang X; Zhang L; Liu Y; Zeng T; Paquette SG; Khan A; Kelvin AA; Kelvin DJ
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7255-64. PubMed ID: 26369969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice.
    Bantia S; Kellogg D; Parker C; Upshaw R; Ilyushina NA; Babu YS
    Antiviral Res; 2011 Apr; 90(1):17-21. PubMed ID: 21316393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection.
    Mishin VP; Hayden FG; Signorelli KL; Gubareva LV
    Antiviral Res; 2006 Aug; 71(1):64-8. PubMed ID: 16581141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models.
    Fukao K; Ando Y; Noshi T; Kitano M; Noda T; Kawai M; Yoshida R; Sato A; Shishido T; Naito A
    PLoS One; 2019; 14(5):e0217307. PubMed ID: 31107922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201.
    Sidwell RW; Smee DF; Huffman JH; Barnard DL; Bailey KW; Morrey JD; Babu YS
    Antimicrob Agents Chemother; 2001 Mar; 45(3):749-57. PubMed ID: 11181355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of single intravenous injection of peramivir against influenza B virus infection in ferrets and cynomolgus macaques.
    Kitano M; Itoh Y; Kodama M; Ishigaki H; Nakayama M; Ishida H; Baba K; Noda T; Sato K; Nihashi Y; Kanazu T; Yoshida R; Torii R; Sato A; Ogasawara K
    Antimicrob Agents Chemother; 2011 Nov; 55(11):4961-70. PubMed ID: 21844317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812).
    Sidwell RW; Bailey KW; Morrey JD; Wong MH; Baldwin TJ; Smee DF
    Antiviral Res; 2003 Sep; 60(1):17-25. PubMed ID: 14516917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of repeated intravenous injection of peramivir against influenza A (H1N1) 2009 virus infection in immunosuppressed mice.
    Kitano M; Kodama M; Itoh Y; Kanazu T; Kobayashi M; Yoshida R; Sato A
    Antimicrob Agents Chemother; 2013 May; 57(5):2286-94. PubMed ID: 23478960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of repeated intravenous administration of peramivir against highly pathogenic avian influenza A (H5N1) virus in cynomolgus macaques.
    Kitano M; Itoh Y; Ishigaki H; Nakayama M; Ishida H; Pham VL; Arikata M; Shichinohe S; Tsuchiya H; Kitagawa N; Kobayashi M; Yoshida R; Sato A; Le QM; Kawaoka Y; Ogasawara K
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4795-803. PubMed ID: 24913156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model.
    Bantia S; Kellogg D; Parker CD; Babu YS
    Antiviral Res; 2010 Dec; 88(3):276-80. PubMed ID: 20943201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.
    Li Z; Li R; Li J; Xie H; Hao Y; Du Q; Chen T; Li Y; Chen R; Yang Z; Zhong N
    BMC Infect Dis; 2016 Jul; 16():325. PubMed ID: 27392915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Amino Acid in the Polymerase Acidic Protein Determines the Pathogenicity of Influenza B Viruses.
    Bae JY; Lee I; Kim JI; Park S; Yoo K; Park M; Kim G; Park MS; Lee JY; Kang C; Kim K; Park MS
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental Infection Using Mouse-Adapted Influenza B Virus in a Mouse Model.
    Prokopyeva E; Kurskaya O; Sobolev I; Solomatina M; Murashkina T; Suvorova A; Alekseev A; Danilenko D; Komissarov A; Fadeev A; Ramsay E; Shestopalov A; Dygai A; Sharshov K
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32326238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of influenza virus replication by plant-derived isoquercetin.
    Kim Y; Narayanan S; Chang KO
    Antiviral Res; 2010 Nov; 88(2):227-35. PubMed ID: 20826184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.